Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "multi-omics"

ResearchBIORXIVMay 9

Preprint: Sex-Stratified Multi-Omics Identifies Sexually Dimorphic Molecular Targets in Parkinsons Disease

Researchers studied how Parkinson's disease affects men and women differently by examining genetic and protein data from thousands of patients. They found that certain genes and biological pathways that cause Parkinson's work differently in males versus females, which could explain why men and women experience this disease differently. This discovery could lead to treatments designed specifically for each sex.

WHY IT MATTERSUnderstanding sex-specific causes of Parkinson's disease could enable doctors to develop targeted treatments that work better for men or women individually, rather than using one-size-fits-all approaches.
👁 Watch this spaceParkinson's disease

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases